A new disclosure filed under the STOCK Act shows Rep. Gilbert Cisneros purchased shares of Cytokinetics, Incorporated (CYTK) in a transaction dated June 30, 2026. The filing lists the purchase as made personally by the member of Congress, with the value falling between $1,001 and $15,000. For anyone who tracks these filings the way people follow senator stock trades or browse capitol trades reddit threads looking for patterns, this one stands out for its timing relative to activity elsewhere around the same stock.
The holding is disclosed through 150 Main Street Trust, held at Bank of America, which is the account structure listed on the periodic transaction report. Whoisbuyingnow.com classifies this filing as a congress buy, meaning the disclosed transaction reflects an acquisition of shares rather than a sale or exchange.
A Notable Cross-Signal
What makes this filing worth a second look is a separate, unrelated disclosure involving the same company. Company insider Malik Fady Ibraham sold CYTK shares on July 21, 2026, in a transaction valued at $27,300. That sale came within roughly three weeks of Cisneros’s reported purchase date, placing both transactions inside a tight 30-day window tied to the same ticker.
Insider sales and congressional purchases are disclosed under different legal frameworks and for different reasons, and nothing in either filing indicates coordination between the two parties. Corporate insiders frequently sell shares for reasons unrelated to company outlook, including tax planning, diversification, or scheduled trading plans, while members of Congress disclose personal trades under the STOCK Act regardless of the underlying rationale. Still, when a member of Congress buys into a stock around the same time a company insider is selling, it’s the kind of overlap that regularly draws attention from readers who track these filings for patterns rather than predictions.
Periodic Transaction Reports like this one are required within 30 to 45 days of a covered transaction, which is why details such as exact dollar amounts are reported in ranges rather than precise figures. The $1,001 to $15,000 band is the lowest disclosure tier under the law, meaning this was a relatively modest purchase in dollar terms even though it’s now part of the public record.
As with all STOCK Act filings, this report is a disclosure of a legally required transaction, not an indication of wrongdoing by either party. Whoisbuyingnow.com will continue monitoring CYTK-related filings from both congressional and corporate insiders for any further activity in the coming weeks.